On Monday, Shares of Apple Inc. (NASDAQ:AAPL), added 1.74% and closed at $116.05 in the last trading session. The last trading range of the stock ranges between $114.72 and $116.75. The company’s Market capitalization is $626.26 Billion with the total Outstanding Shares of 5.39 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $89.47 and reached to max level of $123.82. Attorneys from Dallas’ Caldwell Cassady & Curry have won another multimillion-dollar patent infringement award for Nevada-based VirnetX Holding Corp. (NYSE MKT: VHC) against technology giant Apple Inc. (AAPL) based on an East Texas jury’s finding that Apple owes more than $302 million in royalties for infringing internet security patents owned by VirnetX.
Jurors in the Tyler, Texas, courtroom of Judge Robert W. Schroeder III delivered the verdict in favor of VirnetX on Sept. 30 after one week of trial. The case is VirnetX Inc., et al. v. Apple Inc., No. 6:10-CV-417, in the U.S. District Court for the Eastern District of Texas.
Caldwell Cassady & Curry name principals Bradley W. Caldwell, Jason D. Cassady and J. Austin Curry led the team representing VirnetX. The company also called on Johnny Ward from Ward, Smith & Hill, PLLC, in Longview and attorneys from Parker, Bunt & Ainsworth, P.C., of Tyler. Also representing VirnetX from Caldwell Cassady & Curry were firm principal Justin T. Nemunaitis and firm attorneys Hamad M. Hamad, Warren J. McCarty, Jason S. McManis, Daniel R. Pearson, Christopher S. Stewart, and John F. Summers.
VirnetX formerly won two noteworthyjury awards against Apple with Caldwell Cassady & Curry as lead counsel, counting a 2012 patent infringement verdict of $368 million involving four VirnetX network patents used in iPhones, iPads and other Apple products. Two years later, the U.S. Court of Appeals for the Federal Circuit upheld the jury’s infringement finding on two of the contested patents and confirmed a finding of no invalidity on all four patents before vacating the damages award. That ruling allowed Apple to stop paying royalties and cleared the way for a retrial on damages.
Abbott Laboratories (NYSE:ABT), jumped 1.23% and closed at $43.50 in the last trading session. The last trading range of the stock ranges between $43.06 and $43.78. The company’s Market capitalization is $63.94 Billion with the total Outstanding Shares of 1.47 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $36.00 and reached to max level of $46.38. Abbott (ABT) recently declared that the U.S. Food and Drug Administration (FDA) has approved the company’s FreeStyle Libre Pro system, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals to use with their patients with diabetes.
FreeStyle Libre Pro system is designed to empower healthcare professionals to provide better diabetes administration for diabetes patients. The system provides healthcare professionals with a visual snapshot of glucose data, known as the Ambulatory Glucose Profile (AGP), giving a more simplified and clear overview of not only glucose levels, but also patterns and trends within those levels. This valuable information assists healthcare professionals make better, customized treatment decisions for their patients – and for a significantly lower cost than other professional CGM products availablei.
On nearly a daily basis, Eugene E. Wright, Jr., M.D. of Duke Southern Regional Area Health Education Center in Fayetteville, N.C., finds it challenging to effectively treat his patients with diabetes when it comes to decisions around insulin, nutrition and medication. “My patients are often out of range, because of inconsistent self-monitoring and insufficient data from traditional glucose meters that are unable to provide a full view of their glucose levels.”